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Women have organs they do not feel are their own, 
whose functions are alien to them, and which are used 
by experts in every field.
(Sau, 2000, p. 49)
■■ THE	INVISIBILITY	OF	DIFFERENCE
Medical science was born mainly in hospitals, where 
most pathologies are acute and are predominantly 
male. Women’s complaints, discomfort and pain 
was not always visible, and the 
specific study of differences in 
pathologies between men and 
women did not start until the 
twentieth century. Women’s 
health was studied and 
valued only as part of overall 
reproductive health, and this 
approach prevented exploration 
from a comprehensive 
perspective. 
Lois Verbrugge (1985) was 
the pioneer in research into 
the differences in mortality 
between women and men. Her analyses started to 
prove that there were differences in the diseases that 
most commonly affected each group, highlighting 
the higher prevalence of chronic diseases and use 
of healthcare services among women. Her greatest 
contribution was proving that the perceived health 
status of women – poorer in comparison to men – was 
due to acquired risks and psychosocial aspects such 
as physical inactivity, unemployment, and physical 
and mental state, rather than being caused by innate 
biological differences.
These and other discoveries led medical science, 
which had postulated that studying male specimens 
was equivalent to studying human beings in general, 
to change its paradigms and start recognising that 
there were differences between women and men 
in the way they get sick, in 
symptom manifestation, pain 
causes, the prevalence of 
particular diagnoses, and the 
metabolisation of drugs, which 
act differently depending 
on biological sex or their 
interaction with the menstrual 
cycle. Until 1990, most research 
in all health science areas 
did not include women in 
their study cohorts. No work 
included women in its research, 
and so biological, clinical, 
psychological, social, cultural, and environmental 
considerations regarding the differences between 
women and men were not taken into account.
Thus, research and education biases start with 
the absence of women from research cohorts. The 
living and working conditions of women and their 
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psychosocial overload are not considered. For 
instance, women are considered in the abstract in 
the analysis of the evolution of pathologies, ignoring 
factors such as whether they have children, a family, if 
they are carers, or if they live in stressful conditions. 
We lacked, and are still deficient in, research into 
differential morbidity, disease evolution, and 
differential treatment effects. As we can see, gender 
biases in medicine are perpetuated in many ways, and 
gender stereotypes still remain, as detailed in Mujeres, 
salud y poder (“Women, health, and power”, Valls-
Llobet, 2009).
■■ THE	EFFORT	OF	FEMINIST	RESEARCHERS
Several feminist researchers from around the world 
paved the way for a change in health science research 
and education with a number of publications from 
the 1980s to the 1990s. Apart from Lois Verbrugge, 
we must also mention Sue V. Rosser, who published 
the first book on how to teach health science from 
a feminist perspective in 1986. She advocated for a 
change in study objectives and also in the individuals 
performing the research: 
Health science would be formulated from a perspective 
other than that of the white, middle-and upper-class 
Western men […]. Recognition of the importance of 
perspective leads directly to examining science and 
health from as many perspectives as possible: gender as 
a category of analysis, an interdisciplinary perspective, 
and differing race, class, and cultural perspectives.
(Rosser, 1986, p. 107) 
This was one of feminism’s first contributions to 
health science. Rosser valued and recognised the 
role that social class, ethnicity, and the differences 
between women and men – and among women, 
depending on their age and working conditions 
– could play in pathological processes or in the 
consumption of drugs. The object of study changed 
from abstract entities to specifying the context of 
those under study.
During the 1990s, an international movement of 
female researchers promoted the inclusion of women 
in clinical trials. The first step was taken by the 
North-American cardiologist Bernardine Healy, who, 
in 1993, while she was directing the United States 
National Institutes of Health (NIH), promoted the first 
law that required research projects to include women 
and take ethnicity differences into account in order to 
receive public funding (Freedman et al., 1995).
After these initial steps, albeit with equal measure 
of obstacles and strength, gender perspective was 
gradually incorporated into medical research 
and health care. In the journal JAMA (Journal 
of the American Medical Association), Vivian W. 
Pinn (2003) stated that women’s health research 
had already passed the limits that constrained it 
to reproduction-related organs and hormones. It 
also concluded that health care must be based on 
biological sex differences, and that gender influences 
should be based on behavioural, geographical, 
cultural, economic, and social factors.
In the discussion about how to address science 
without hiding differences, while also integrating 
social conditions and biological differences, the 
biologist Evelyn Fox Keller deconstructed many of 
the stereotyped paradigms in health science, such as 
the role of egg and sperm cells in reproduction. For 
example, those who imaginatively described «brave 
sperm overcoming barriers and navigating through 
vaginas» did not consider the metabolic changes that 
occur in the egg at the same time which provide the 
necessary substrate for embryo formation. For Keller 
(2004), the impact of feminism on science should not 
be based on essences of femininity: «My aim was 

























“feminine”, but rather, to make it more truly objective, 
and, necessarily, “gender-free”» (p. 7).
To start this process, we will probably have to 
find new language to define sexes and the individual 
differences between them. Thus, Anne Fausto-
Sterling (2006) defines five sexes: male, female, 
herms (individuals born with one testicle and one 
ovary), merms (born with testicles but also with 
signs of female genitalia), and ferms (born with 
ovaries but with some features of male genitalia); 
between 1.7 % and 4 % of people are thought to be 
intersex. 
Anne Fausto-Sterling has profoundly studied 
whether there are neurological differences between 
women and men, in particular with the example of 
the corpus callosum – the interconnections between 
brain hemispheres – whose size is double in women 
compared to men. Is it a real difference or a difference 
in perception? Is neurological development related 
to the fact that mothers talk, touch, and move their 
young male offspring more than they do their female 
offspring, which thus invokes greater psychomotor 
stimulation? For Fausto-Sterling, establishing current 
highly stereotypical differences may respond to our 
need to find easy, normalising explanations for the 
alleged inferiority of women and other ethnic groups. 
New work can shed more light on the differences 
in human brains according to sex; an example is a 
study carried out with 1,400 men and women (Joel 
et al., 2015) to observe whether or not there were 
sex-dependent anatomical differences. The authors 
concluded that, in the context of their sample and 
methodology, variability is found between individuals 
of the same sex, but no great differences were 
observed between women and men.
Many questions remain unanswered, but I think 
that only misogynistic researchers with already 
biased minds would interpret the differences between 
sexes as inferiority. Today we already know that 
human brains develop through interaction with the 
environment and this development can be positively 
modified or stopped due to nutritional aspects or the 
quality of the natural environment – water, air, and 




Sandra Harding, in her classic book The science 
question in feminism, explores gender contradictions 
in science and androcentrism in biology and social 
science, pointing out how science gets used for 
classist, sexist, racist, and homophobic projects, or 
how the design and interpretation of inquiry has been 
developed again and again with a male gender bias. 
When we began theorizing our experiences during 
the second women’s movement a mere decade and a 
half ago, we knew our task would be a difficult though 
exciting one. But I doubt that in our wildest dreams we 
ever imagined we would have to reinvent both science 
and theorizing itself to make sense of women’s social 
experience.
(Harding, 1996, p. 217) 
The contribution of feminism to social and health 
sciences was not limited to bringing previously 
hidden relations to the spotlight, or to unmasking 
partial conclusions; the way we research was also put 
into question (Díaz, 2002).
■■ INTRODUCING	SEX	AND	GENDER	IN	
BIOMEDICAL	SCIENCE
Research in all health fields, from basic cell and 
molecular biology to neuroscience, did not take 
gender differences into account, and thus, required 
an appropriate methodology to properly study 
them; investigation into this methodology is also 








the work undertaken at 
Stanford University; under 
the management of Londa 
Schiebinger; they created 
a platform for studying sex 
and gender differences and 
innovating in this field: 
Gendered Innovations.1
Universities must 
all develop this task of 
differential sex and gender 
analysis, but, in basic 
biomedical research, we must 
also reflect upon the research 
conditions. For example, when 
performing cancer research 
using cell lines, are we taking 
into account any potential 
differences derived from their 
origin in a man or a woman? 
If we perform research using 
cells isolated in vitro, can we 
deduce if there will be any 
differences in behaviour inside 
the body of a woman or a man, when interacting 
among themselves, with different sex hormones, or in 
stress conditions?
Karen Messing and Donna Mergler’s research 
group, at the Center for Interdisciplinary Research 
on Well-Being, Health, Society, and Environment 
(CINBIOSE) in Canada, propose that we take time 
to reflect upon these issues at each research step, and 
state that every member of the team must develop sex 
and gender knowledge. Ultimately, the possible sex 
and gender implications of all research findings from 
any lab should always be discussed (Ritz et al., 2014).
In order to assess the quality of sex and gender 
additions to health research work, a team of 
researchers at the University of Zaragoza have 
developed a questionnaire containing almost twenty 
questions aimed at assessing gender perspectives 




Current clinical medicine biases the visibility of the 
most prevalent diagnostics in women in many ways: 
from ignoring menstruation-related disorders during 
adolescence to magnifying the consequences of the 
1 http://genderedinnovations.stanford.edu/
natural process of menopause, together with the 
appearance of chronic pathologies that produce pain 
and are more frequent among women (Valls-Llobet, 
2006). 
Underlying beliefs in the subconscious of many 
health professionals bias the clarity with which they 
address the diagnosis process and the treatment of 
many pathologies. Diagnostics are overshadowed by 
the assumption that risks and morbidity are equal 
in men and women, when in fact they are often 
different. Conversely, they consider biological or 
psychological differences where there are actually 
similarities. In the case of health care for women, 
complaints or symptoms are more frequently 
considered psychosomatic, so they are often 
prescribed anxiolytics and antidepressants at their 
first consultation. It is also frequent to minimise or 
maximise the pathology of a woman and the results of 
laboratory analyses without a scientific basis, exercise 
a reductionist paradigm of aetiologies, or mishandle 
the cause and effect relationship. 
In addition, the fact that risks and toxicities are 
sometimes different for women and men, is often 
overlooked. For instance, the female body is a 
primary environmental chemical bioaccumulator 
(e.g., of pesticides, solvents, plastic derivatives, 
hydrocarbons from cars, etc.), because of their 
naturally higher body fat content.
■■ ADVANCEMENTS	IN	THE	LAST	FIFTEEN	YEARS
Since the end of the twentieth century, we have 
come to understand the incorporation of gender 
perspectives in education at many universities and 
in public policy as an advancement. The resolutions 
of the European Parliament regarding the situation 
of women’s health in the European Community 
(collected in the Official Journal of the European 
Communities on 21 June 1999) are good examples. 
They are backed by the conclusions of the first 
International Congress on Women, Work, and Health, 
held in 1996 in Barcelona. The resolutions refer to 
the specificity of women’s health problems and the 
existence of differences in general health between the 
sexes, and state that health care policy also requires 
differential treatment. Therefore, it recommends that 
member states should take these issues into account 
both in health analyses and in future actions. 
Thus, the strategic plan of the National Institutes 
of Health in the United States (NIH Strategic Plan 
for Women’s Health Research), within the Moving 
Into the Future with New Dimensions and Strategies: 

































framework from the NIH Office 
of Research on Women’s Health 
(ORWH), is great news for the 




Without the support of health 
care services empowering the 
science of difference, it is very 
difficult – for some women 
almost impossible – to change 
attitudes and values in a body that feels tired or 
exhausted after a double shift, because of the micro-
violence in life, at work, or in personal relationships, 
or due to nutritional deficiencies or endocrine and 
menstrual dysfunctions, in addition to those caused 
by the environment or by the excessive medicalisation 
of their body. In order to truly support them, medical 
science must take into account the differences 
in the way women get sick and the different risk 
factors in men and women. Thus, an increase in 
research and education about differential morbidity, 
stress, and mental and physical health is required. 
2 http://orwh.od.nih.gov/research/strategicplan/
The health care system needs to be progressively 
more sensitive to gender issues, creating specific 
spaces and protocols to make differential diagnosis 
easier. Therefore, the science of difference should be 
included in research and taught in all health science 
specialisations. 
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«RESEARCH IN ALL HEALTH 
FIELDS, FROM BASIC CELL 
AND MOLECULAR BIOLOGY 
TO NEUROSCIENCE, DID NOT 
TAKE GENDER DIFFERENCES 
INTO ACCOUNT, AND THUS, 
REQUIRED AN APPROPRIATE 
METHODOLOGY TO 
PROPERLY STUDY THEM»
